Navigation Links
Consumer Reports Health Questions Use of Statins By Children and Some Women

Analyzes the Effectiveness and Safety of Statin Use for Those Who Need It

Recommendations for Choosing a 'Best Buy' Statin and Strategies for Money-Saving

YONKERS, N.Y., June 29 /PRNewswire-USNewswire/ -- A series of new reports from Consumer Reports Best Buy Drugs (BBD) caution that the benefits of statin use by children and some women may not outweigh the risks. Drugs to lower cholesterol — including statins — are the most commonly prescribed drugs in the U.S. and garnered more than $14 billion in sales last year.

The BBD reports also analyze the effectiveness of statin drugs to lower cholesterol, reduce the risk of heart attack and death and to treat people who have cardiovascular disease. The report finds that a number of low-cost generic statins are as effective and safe as more expensive brand-name drugs in reducing these risks. The Consumer Reports BBD reports coincide with the introduction of Livalo, the so-called 7th statin, in an already crowded class of drugs.

The reports, available for free at, note that there are no long-term studies of statin use in kids that establish whether or not these medications reduce the number of heart attacks or other cardiovascular events in adulthood. There is also concern over the long-term potential risk for children and adolescents who use these medications for years or decades, particularly the effects on the developing central nervous system, organs, immune function, and hormone levels.  For women who only have high LDL, the bad cholesterol, and no heart disease, the risks of statins might outweigh the benefits. Risks include headache, joint and muscle pain, and diarrhea. Other risks that are rarer include liver damage and rhabdomylosis, a breakdown of muscle tissue that can lead to coma and even death. There is also an association with an increased risk of type 2 diabetes.

"Contrary to what many consumers believe, we don't have solid medical evidence supporting the use of statins in children and there is no long-term safety data tracking kids who take statins for 10 or 20 years.  And when it comes to healthy women, statins' limited benefits may not outweigh their risks," said John Santa, M.D., M.P.H., director of the Consumer Reports Health Ratings Center.

Since the first statin, lovastatin, came on the market in 1987, statins have been a boon to the pharmaceutical industry.  Cholesterol-lowering drugs were the most commonly prescribed drugs in the U.S. in 2009 and collectively earned more than $14 billion dollars last year alone, according to IMS Health.  When adults have high levels of low-density lipoprotein (LDL), known as the bad cholesterol, they are at increased risk of heart disease and heart attack.  Statins lower LDL cholesterol levels and can decrease blockages in the arteries that supply the heart, brain and leg muscles in people who have atherosclerosis.  

The Seventh Statin: What It Means for Consumers

The Consumer Reports BBD reports coincide with the arrival of Livalo, the so called "7th Statin," which industry watchers expect to be promoted as a high potency drug, though it has not earned solid proof of preventing a cardiovascular event.  "With Livalo arriving on market, there's the potential for consumers to hear just one message — save your life, get the hot new statin. Our concern is that consumers may not need such a high-potency statin, or they may not need one at all.  And if a statin is needed, much more is known about the safety profile and side affects of the older statins," said Santa.  According to a 2009 poll by the Consumer Reports National Research Center, one in five adults have asked a doctor for a drug they saw advertised and the majority of those requests were granted.

For people who do need to take a statin, Consumer Reports Best Buy Drugs recommends the best choices based on a systematic review of the medical evidence, noting that the use of a high potency statin such as Crestor, Lipitor, Livalo, or generic simvastatin should be reserved for patients who need to reduce their LDL cholesterol by more than 30 percent. Evidence has mounted in recent years that the risk of life-threatening rhabdomyolysis from statins increases with the use of higher doses.

For people who need to lower their LDL by less than 30 percent, Consumer Reports Best Buy Drugs recommends starting with generic lovastatin or pravastatin.  These generics can be purchased for as little as $15 a month versus $125 for a branded drug like Crestor; the savings over a year can add up to as much as $1,300.  Since using a statin drug is considered a lifetime commitment, the savings over several years can amount to virtually thousands, even tens of thousands, of dollars.  Lipitor, the #1 highest selling branded drug in the U.S., costs up to $168 a month but is expected to become available as a lower-cost generic in 2011.

Guidance for Parents of Children with Elevated LDL

In a detailed report about kids and statins, Consumer Reports Best Buy Drugs speaks to a growing audience of parents whose children have about a one in five chance of becoming obese and, according to recent estimates by the Centers for Disease Control and Prevention (CDC), the same likelihood of lipid abnormalities.  Consumer Reports BBD suggests the following considerations for parents weighing long-term statin therapy for their children:

  • First, identify whether your child has any of the traditional risk factors for cardiovascular disease: being overweight or obese; having diabetes; having a family history of premature heart disease; or being a smoker.
  • If your child does have one of these risk factors, improve the child's diet and increase physical activity with a goal of weight loss if it is needed.  Lowering your child's cholesterol without a drug is preferable.  
  • For children who have elevated cholesterol but do not have traditional risk factors for heart disease and are otherwise healthy, there is a substantial lack of evidence that treating high cholesterol in this group would reduce the number of heart attacks.  Consumer Reports BBD notes that to date, there are no long-term studies that show whether or not doing so reduces the number of heart attacks or other cardiovascular events as the child becomes an adult.  
  • For children with traditional risk factors for heart disease, such as having diabetes or high blood pressure, smoking, those who are overweight or obese (high BMIs), or those with a family history of early-onset heart disease, cholesterol levels may be more important. But lifestyle changes are particularly crucial for this age group, and they include losing weight if needed, increasing exercise and improving a child's diet for at least two years before considering a drug therapy.
  • A 2009 poll by the Consumer Reports National Research Center suggests that consumers think otherwise.  Only half of consumers are correctly informed about evidence supporting prescription medicines used to treat children. One third (32%) of Americans are under the false impression that drugs to treat conditions in children have always been proven to be safe and effective in children.

Why Some Women Should Think Twice

Today, 22 percent of Americans 45 or older take statins. There are many women within this group and some may have a low risk for cardiovascular disease (CVD). That is an issue because understanding the benefit statins have for these women has not been clear-cut. Some research has been inconclusive due to the use of significantly fewer women than men in trials. And in some cases, trial results were not initially broken down according to gender. Other analyses have found that statin use did not appear to have a beneficial effect on total mortality for women with or without previous CVD. Consumer Reports BBD offers some considerations to help guide decision-making:  

  • Women with elevated LDL cholesterol and no other heart disease risk factors can determine their 10-year risk of heart attack by using a free online tool provided by the National Cholesterol Education Panel:
  • For women with already low or very low risk, as determined by the calculator, there are other actions they can take to reduce the risk of heart attack or heart disease, including stopping smoking, losing weight if needed, increasing exercise, eating a "heart-healthy diet," and taking steps to curb stress.
  • Women's cholesterol might naturally rise after menopause. High levels of HDL, or "good" cholesterol, are beneficial.

For women who require a statin:

  • With all their benefits, statins have downsides that should be considered. Five to 10 percent of users experience mild to severe muscle pain and weakness.   An estimated one percent of people who take statins might develop abnormal liver-function tests.  As with many drugs, we know a lot more about the short-term side effects of statins, like diarrhea and nausea, than the longer-term effects.  That's why statin users should be checked regularly by their doctor.
  • Ask your doctor for the lowest dose possible to achieve your goal of cholesterol reduction.   For most people, a generic statin will be as effective and safe as a branded medicine, and it will cost less.  If you begin to have significant muscle aches after taking a statin, review alternate options with your doctor.
  • The majority of statins can be split in half without any loss of effectiveness.  Good candidates for splitting pills are those statins that cost the same at higher doses, such as Lipitor which costs up to $168 for a monthly supply of 20mg, 40 mg, or 80 mg.  When larger doses cost the same as the smaller dose, you can save money by getting the larger dose and splitting the pills in half.  Consumer Reports BBD recommends talking to your doctor before splitting your statin pills. For a guide to safe and effective pill splitting, go to  

JULY 2010

Consumers Union 2010.  The material above is intended for legitimate news entities only; it may not be used for advertising or promotional purposes. Consumer Reports® is published by Consumers Union, an expert, independent nonprofit organization whose mission is to work for a fair, just, and safe marketplace for all consumers and to empower consumers to protect themselves.  We accept no advertising and pay for all the products we test. We are not beholden to any commercial interest. Our income is derived from the sale of Consumer Reports,®® and our other publications and information products, services, fees, and noncommercial contributions and grants. Our Ratings and reports are intended solely for the use of our readers. Neither the Ratings nor the reports may be used in advertising or for any other commercial purpose without our permission. Consumers Union will take all steps open to it to prevent commercial use of its materials, its name, or the name of Consumer Reports.®

SOURCE Consumer Reports
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
2. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
3. Dog Law Officers Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers
4. Survey Finds At-Risk Consumers Interested in OTC Statin
5. Florastor(R) Receives Certification
6. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
7. Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
8. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
9. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
10. IncentOne Introduces Next Generation of Healthy Choice Award(TM) Incentive Solution to Drive Consumer and Provider Engagement
11. comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
Post Your Comments:
(Date:10/13/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... serving the pharmaceutical, biotechnology, and medical device industries, ... version of OncoWuXi, the first App in the ... and data on the go.  The OncoWuXi App ... to identify relevant tumor models for use in ...
(Date:10/13/2015)... Oct. 13, 2015  The Wyss Institute ... today announced the launch of its latest ... will introduce imaging reagents providing super-resolution capabilities ... of expensive specialized instruments. The announcement follows ... Office of Technology Development (OTD) and ...
(Date:10/13/2015)... -- --> --> Opportunities ... the Asthma and COPD Therapies market? Which areas are going ... new report shows you potential revenues to 2025, assessing data, ... 260 tables, charts, and graphs. Discover the most lucrative areas ... study lets you assess forecasted sales at overall world market ...
Breaking Medicine Technology:
(Date:10/13/2015)... MA (PRWEB) , ... October 13, 2015 , ... Protein ... of the body, including muscle, bone, and blood. But how much protein does the ... complicated than it might seem, according to the October 2015 issue of Harvard ...
(Date:10/13/2015)... ... October 13, 2015 , ... T-System and Centegra ... than 59,000 emergency department visits per year, today announced the successful and rapid ... improve clinical, operational and financial outcomes. , In less than four ...
(Date:10/13/2015)... ... October 13, 2015 , ... World Patent Marketing , a vertically ... melting invention that helps people in clearing snow away from the streets and driveways. ... at 3.8% per year," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, ... the newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to ... leading professional in Obstetrics and Gynecology and a pioneer in the field of ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... and the Florida Apartment Association (FAA) has partnered with the Florida Department of ... the demand. , The FAA Smoke-Free Multifamily Housing Program launched last week ...
Breaking Medicine News(10 mins):